blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2376074

EP2376074 - METHOD FOR IMPROVED BIOACTIVATION OF MEDICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.01.2020
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  08.02.2019
FormerGrant of patent is intended
Status updated on  17.07.2018
FormerExamination is in progress
Status updated on  11.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
Berliner Strasse 1
12529 Schönefeld/OT Waltersdorf / DE
[2011/42]
Inventor(s)01 / CLEMENT, Bernd
Johann-Fleck-Str. 27
24106 Kiel / DE
02 / SCHADE, Dennis
Hasseldieksdammer Weg 5
24114 Kiel / DE
 [2011/42]
Representative(s)Zech, Stefan Markus, et al
Meissner Bolte Patentanwälte
Rechtsanwälte Partnerschaft mbB
Postfach 86 06 24
81633 München / DE
[2019/11]
Former [2011/42]Zech, Stefan Markus, et al
Meissner, Bolte & Partner GbR Postfach 86 06 24
81633 München / DE
Application number, filing date10706476.808.01.2010
[2019/11]
WO2010DE00009
Priority number, dateDE2009100420409.01.2009         Original published format: DE102009004204
[2011/42]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2010078867
Date:15.07.2010
Language:DE
[2010/28]
Type: A1 Application with search report 
No.:EP2376074
Date:19.10.2011
Language:DE
The application published by WIPO in one of the EPO official languages on 15.07.2010 takes the place of the publication of the European patent application.
[2011/42]
Type: B1 Patent specification 
No.:EP2376074
Date:13.03.2019
Language:DE
[2019/11]
Search report(s)International search report - published on:EP15.07.2010
ClassificationIPC:A61K31/155, C07C257/10, C07D309/28, C07C279/18, C07C257/18
[2018/28]
CPC:
C07C279/18 (EP,US); C07C257/10 (KR); A61K31/155 (KR);
A61P11/00 (EP); A61P25/00 (EP); A61P31/12 (EP);
A61P31/16 (EP); A61P31/18 (EP); A61P33/02 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/12 (EP); C07C217/02 (KR);
C07C257/18 (EP,US); C07C259/12 (KR); C07D309/28 (EP,US);
Y02A50/30 (EP) (-)
Former IPC [2011/42]A61K31/155, C07C257/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2019/11]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR VERBESSERTEN BIOAKTIVIERUNG VON ARZNEISTOFFEN[2011/42]
English:METHOD FOR IMPROVED BIOACTIVATION OF MEDICATIONS[2011/42]
French:PROCÉDÉ POUR AMÉLIORER LA BIOACTIVATION DE SUBSTANCES PHARMACEUTIQUES[2011/42]
Entry into regional phase15.07.2011National basic fee paid 
15.07.2011Designation fee(s) paid 
15.07.2011Examination fee paid 
Examination procedure15.07.2011Examination requested  [2011/42]
27.02.2012Amendment by applicant (claims and/or description)
15.04.2013Despatch of a communication from the examining division (Time limit: M06)
25.10.2013Reply to a communication from the examining division
01.07.2016Despatch of a communication from the examining division (Time limit: M04)
10.11.2016Reply to a communication from the examining division
18.07.2018Communication of intention to grant the patent
28.11.2018Fee for grant paid
28.11.2018Fee for publishing/printing paid
28.11.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.04.2013
Opposition(s)16.12.2019No opposition filed within time limit [2020/08]
Fees paidRenewal fee
30.01.2012Renewal fee patent year 03
30.01.2013Renewal fee patent year 04
30.01.2014Renewal fee patent year 05
29.01.2015Renewal fee patent year 06
29.01.2016Renewal fee patent year 07
27.07.2017Renewal fee patent year 08
31.01.2018Renewal fee patent year 09
30.01.2019Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.01.201708   M06   Fee paid on   27.07.2017
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.01.2010
CY13.03.2019
CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
MC13.03.2019
MK13.03.2019
MT13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SI13.03.2019
SK13.03.2019
SM13.03.2019
TR13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
[2022/32]
Former [2022/27]HU08.01.2010
CY13.03.2019
CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
MC13.03.2019
MT13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SI13.03.2019
SK13.03.2019
SM13.03.2019
TR13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2020/39]CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
MC13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SI13.03.2019
SK13.03.2019
SM13.03.2019
TR13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2020/17]CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SI13.03.2019
SK13.03.2019
SM13.03.2019
TR13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2020/13]CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SI13.03.2019
SK13.03.2019
SM13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2020/09]CZ13.03.2019
DK13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SK13.03.2019
SM13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2020/04]CZ13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SK13.03.2019
SM13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
IS13.07.2019
PT13.07.2019
Former [2019/52]CZ13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
PL13.03.2019
RO13.03.2019
SE13.03.2019
SK13.03.2019
SM13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
PT13.07.2019
Former [2019/49]CZ13.03.2019
EE13.03.2019
ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
RO13.03.2019
SE13.03.2019
SK13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
PT13.07.2019
Former [2019/48]ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
SE13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
PT13.07.2019
Former [2019/47]ES13.03.2019
FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
SE13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
Former [2019/46]FI13.03.2019
HR13.03.2019
IT13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
SE13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
Former [2019/39]FI13.03.2019
HR13.03.2019
LT13.03.2019
LV13.03.2019
NL13.03.2019
SE13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
Former [2019/38]FI13.03.2019
LT13.03.2019
SE13.03.2019
BG13.06.2019
NO13.06.2019
GR14.06.2019
Former [2019/37]FI13.03.2019
LT13.03.2019
SE13.03.2019
NO13.06.2019
GR14.06.2019
Former [2019/34]FI13.03.2019
LT13.03.2019
SE13.03.2019
NO13.06.2019
Former [2019/33]FI13.03.2019
LT13.03.2019
NO13.06.2019
Cited inInternational search[X]US5610144  (CAPET MARC [FR], et al) [X] 1-3,13,14 * column 99, line 33 - line 67; example 115 *;
 [X]US5840758  (BROOKS CLINT D W [US], et al) [X] 1-3,13-15 * column 9 - column 10; examples 1,9-12,20-22; claims 1-13 *;
 [Y]US2002019437  (BOYKIN DAVID W [US], et al) [Y] 1-4,6-9,11,13-17 * paragraphs [0002] , [0003] , [0007] - [0017] - [0019] , [0026] * * table 1 *;
 [XY]EP1561463  (UNIV NORTH CAROLINA [US], et al) [X] 9 * paragraphs [0001] , [0005] - [0008] - [0064] , [0065] * * paragraph [0065] * [Y] 1-4,6-9,11,13-17;
 [XY]WO2006045514  (APPLIED RESEARCH SYSTEMS [NL], et al) [X] 1,3,13,14 * page 18, paragraph last - page 19, paragraph 1; claims 1-14; compound 92 * * page 20, paragraph 4 * [Y] 2,4,6-9,11,15-17;
 [X]US2007093432  (YANG LI-XI [US]) [X] 1,13,14 * page 35; compounds 2, 2a, 2b * * page 36; compounds 5,6 *;
 [IY]WO2008009264  (UNIV KIEL CHRISTIAN ALBRECHTS [DE], et al) [I] 1-9,13-17 * page 2 - page 5; figures 1-4; claims 1-8 * [Y] 1-4,6-9,11;
 [X]EP2009006  (TORAY INDUSTRIES [JP]) [X] 1,2,13,14 * page 127 * * table 1 *;
 [XP]WO2009092358  (SCHAPER WOLFGANG [DE]) [XP] 1-3 * the whole document *;
 [IP]WO2009095499  (DRITTE PATENTPORTFOLIO BETEILI [DE], et al) [IP] 1-19 * the whole document *;
 [IP]WO2009095503  (DRITTE PATENTPORTFOLIO BETEILI [DE], et al) [IP] 1-19 * the whole document *;
 [Y]  - REHSE ET AL, "New NO Donors with Antithrombotic and Vasodilating Activities, Part 26 Amidoximes and Their Prodrugs", ARCHIV DER PHARMAZIE, VCH VERLAGSGESELLSCHAFT MBH, WEINHEIM, DE LNKD- DOI:10.1002/(SICI)1521-4184(199812)331:12<375::AID-ARDP375>3.0.CO;2-F, (19980101), vol. 331, no. 12, ISSN 0365-6233, pages 375 - 379, XP009132776 [Y] 1-4,6-9,11,13-17 * abstract *

DOI:   http://dx.doi.org/10.1002/(SICI)1521-4184(199812)331:12<375::AID-ARDP375>3.0.CO;2-F
 [Y]  - FROEHLICH A K ET AL, "Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyltransferases", XENOBIOTICA, (200501), vol. 35, no. 1, ISSN 0049-8254, pages 17 - 25, XP009132770 [Y] 1-4,6-9,11,13-17 * figure 1 *
 [Y]  - RIGGS J R ET AL, "Factor VIIa inhibitors: A prodrug strategy to improve oral bioavailability", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB LNKD- DOI:10.1016/J.BMCL.2006.01.039, vol. 16, no. 8, ISSN 0960-894X, (20060415), pages 2224 - 2228, (20060415), XP025106943 [Y] 1-4,7,9,13-17 * tables 1,2 * * Schema 1, 2 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2006.01.039
 [Y]  - ANSEDE J H ET AL, "In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis", XENOBIOTICA, TAYLOR AND FRANCIS, LONDON, GB LNKD- DOI:10.1080/00498250500087671, (20050301), vol. 35, no. 3, ISSN 0049-8254, pages 211 - 226, XP009132798 [Y] 1-4,6,9,13-17 * the whole document *

DOI:   http://dx.doi.org/10.1080/00498250500087671
 [Y]  - CLEMENT B ET AL, "AMIDOXIMES OF PENTAMIDINE: SYNTHESIS, TRYPANOCIDAL AND LEISHMANICIDAL ACTIVITY", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, (19850101), vol. 35, no. 7, ISSN 0004-4172, pages 1009 - 1014, XP000566459 [Y] 1-4,6-9,11,13-17 * the whole document *
 [XP]  - SCHADE D ET AL, "The peptidylglycine a-amidating monooxygenase (PAM): A novel prodrug strategy for amidoximes and N-hydroxyguanidines?", CHEMMEDCHEM 2009 JOHN WILEY AND SONS LTD GBR LNKD- DOI:10.1002/CMDC.200900233, (20091001), vol. 4, no. 10, pages 1595 - 1599, XP007912822 [XP] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1002/cmdc.200900233
 [IP]  - SCHRODER A ET AL, "Arylazoamidoximes and related compounds as NO-modulators", ARCHIV DER PHARMAZIE 2010 WILEY-VCH VERLAG DEU LNKD- DOI:10.1002/ARDP.200900060, (201001), vol. 343, no. 1, pages 9 - 16, XP007912819 [IP] 1-19 * the whole document *
 [A]  - FRANZ ESSER ET AL, "Cyclic guanidines. Part 6. Synthesis of benzimidazoles by intramolecular vicarious nucleophilic substitution of hydrogen", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1, CHEMICAL SOCIETY, LETCHWORTH; GB LNKD- DOI:10.1039/A900553F, (19990101), ISSN 0300-922X, pages 1153 - 1154, XP007912863 [A] 18,19 * Schema 1 *

DOI:   http://dx.doi.org/10.1039/a900553f
 [A]  - PETERLIN-MASIC L ET AL, "Metabolism-Directed Optimisation of Antithrombotics: The Prodrug Principle", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL LNKD- DOI:10.2174/138161206775193172, (20060101), vol. 12, no. 1, ISSN 1381-6128, pages 73 - 91, XP009132773 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.2174/138161206775193172
 [A]  - MARRIOTT HELEN M ET AL, "Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (20061101), vol. 177, no. 9, ISSN 0022-1767, pages 6480 - 6488, XP007912841 [A] 1-17 * the whole document *
ExaminationDE2640484
 US5225408
 US5587372
    - WELLER H N ET AL, "SYNTHESIS OF N-ALKYL-1,2,4-OXADIAZINONES AS ANGIOTENSIN-II (AT1) RECEPTOR ANTAGONISTS", HETEROCYCLES.INTERNATIONAL JOURNAL FOR REVIEWS AND COMMUNICATIONS IN HETEROCYCLIC CHEMISTRY, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (19930101), vol. 36, no. 5, ISSN 0385-5414, pages 1027 - 1038, XP001007292
by applicantDE4321444
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.